Tony Hoos currently serves as the Chief of Medical for Amgen in Europe, which includes all therapeutic areas as well as all medical departments in Europe. Tony has been passionate about patient involvement in the development and life cycle of medicines for many years. He has worked extensively with stakeholders to involve patients in the benefit-risk assessment of medicines and he is one of the founders of ‘Patient Focused Medicines Development’ (PFMD), which is a multi-stakeholder initiative consisting of patient organizations and industry in the US and Europe. Prior to Amgen, Tony was a Senior Vice President for GSK at the corporate headquarters in London; his responsibilities over time included European Medical Affairs, Head of the Rare Disease Business Unit and senior associate of the Chief Medical Officer. Prior to joining GSK, Tony was a member of the Executive Management Board of Merck Serono (Geneva, Switzerland); his area of responsibility was Global Drug Development, including Regulatory Affairs, Pharmacovigilance and Medical Affairs. Overall Tony has 25 years of experience in pharmaceutical industry in various global management and medicines development roles for companies in the United States and Europe, including a long career with Aventis and its predecessor companies. Dr. Hoos is a licensed physician; he studied and trained in Germany and the US. He also holds a Masters of Business Administration from the University of Toronto, Canada.